Live feed
Filing
SC 13G
SC 13G0001770632-19-000002·Hepion Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
CONTRAVIR PHARMACEUTICALS IN
Security class unavailable · CUSIP: 21234W202
Event date: 2019-03-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001770632-19-000002
- Form type
- SC 13G
- Filer
- Hepion Pharmaceuticals, Inc.
- CIK
- CIK 1583771
- Filed
- Mar 15, 2019
- Reporting period
- Mar 05, 2019
- Description
- Schedule 13G beneficial ownership